Torbé Andrzej, Czajka Ryszard
Chair and Department of Obstetrics and Perinatology, Al. Powstañców Wielkopolskich 72, 70-111 Szczecin, Poland.
Eur J Obstet Gynecol Reprod Biol. 2004 Oct 15;116(2):177-81. doi: 10.1016/j.ejogrb.2003.12.031.
Although the usefulness of procalcitonin (PCT) in clinical practice is increasing, no data are available on procalcitonin during pregnancy. The purpose of this study was to investigate whether procalcitonin was present in the cervicovaginal secretion of pregnant women and, if so, to evaluate the practical value of determining the concentration.
A total of 53 patients in whom preterm labor (PTL) was expected and 31 healthy pregnant women were enrolled in this study. In the preterm labor group procalcitonin concentrations were analyzed with reference to laboratory indices suggestive of infection. The outcome of pregnancy was recorded in each case, with mention of the gestational age at delivery and of the time between admission to hospital and delivery.
Concentrations of procalcitonin in the preterm labor group were comparable to those in the healthy pregnant women. In the preterm labor group no significant correlations were observed between procalcitonin concentration and laboratory indices of infection. Nor were any correlations observed between procalcitonin concentration at the onset of preterm labor and gestational age either at the onset of labor or at delivery. However, procalcitonin concentrations at the onset of preterm labor were higher in patients who delivered prematurely than in those who delivered near term after treatment to delay labor. Procalcitonin concentrations in women whose babies were delivered within 3, 7 and 14 days of admission and in those whose babies were born at later times were comparable.
In this study, procalcitonin was determined in the cervicovaginal secretion of pregnant women for the first time. However, no association was observed either between procalcitonin concentration at the onset of preterm labor and laboratory signs of infection or between procalcitonin concentration and time between admission to hospital and delivery. Procalcitonin determination would be unsatisfactory as a prognostic indicator of the length of time between admission to hospital and delivery.
尽管降钙素原(PCT)在临床实践中的应用价值日益增加,但尚无关于孕期降钙素原的相关数据。本研究的目的是调查孕妇宫颈阴道分泌物中是否存在降钙素原,若存在,则评估测定其浓度的实用价值。
本研究共纳入53例预计早产(PTL)的患者和31例健康孕妇。在早产组中,参照提示感染的实验室指标分析降钙素原浓度。记录每例患者的妊娠结局,包括分娩时的孕周以及入院至分娩的时间。
早产组的降钙素原浓度与健康孕妇相当。在早产组中,降钙素原浓度与感染的实验室指标之间未观察到显著相关性。早产发作时的降钙素原浓度与发作时或分娩时的孕周之间也未观察到相关性。然而,早产发作时,早产分娩的患者降钙素原浓度高于经治疗延迟分娩至足月分娩的患者。入院后3天、7天和14天内分娩的妇女以及在更晚时间分娩的妇女的降钙素原浓度相当。
在本研究中,首次在孕妇的宫颈阴道分泌物中检测到降钙素原。然而,早产发作时的降钙素原浓度与感染的实验室指标之间以及降钙素原浓度与入院至分娩的时间之间均未观察到关联。降钙素原测定作为入院至分娩时间的预后指标并不理想。